Commerzbank Aktiengesellschaft’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio NWBO Stock Details NWBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-23,500	Closed	-$233K	–	1244
2015 Q2	$233K	Buy	23,500 +2,500	+12%	+$21.9K	﹤0.01%	1102
2015 Q1	$155K	Sell	21,000 -166,950	-89%	-$1.12M	﹤0.01%	1100
2014 Q4	$1.01M	Buy	187,950 +25,160	+15%	+$129K	0.01%	845
2014 Q3	$819K	Buy	162,790 +500	+0.3%	+$3.07K	﹤0.01%	868
2014 Q2	$1.09M	Buy	162,290 +90,630	+126%	+$577K	0.01%	837
2014 Q1	$519K	Buy	+71,660	New	+$425K	﹤0.01%	963

Other funds holding NWBO

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Commerzbank Aktiengesellschaft's NWBO Position: Q3 2015 in Review

Commerzbank Aktiengesellschaft sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q3 2015, closing a stake of 23,500 shares — an estimated $233K sold.

Commerzbank Aktiengesellschaft first reported a position in NWBO in Q1 2014 and held it in 6 quarters. The position peaked at $1.09M in Q2 2014. 79 funds tracked by Wall St. Rank hold NWBO as of Q3 2015.

Commerzbank Aktiengesellschaft reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q3 2015 after selling out during the quarter.
Commerzbank Aktiengesellschaft sold 23,500 Northwest Biotherapeutics, Inc. Common stock shares in Q3 2015, an estimated $233K.
Commerzbank Aktiengesellschaft first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q1 2014 and held it in 6 quarters.
Commerzbank Aktiengesellschaft's Northwest Biotherapeutics, Inc. Common stock position peaked at $1.09M in Q2 2014.
79 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q3 2015.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q3 2015, filed 29 Oct 2015.